Search research articles
Contact Us
Filters
Showing results (101-110 of 134) with videos related to
Page
of 14
Sort By:
Anticancer Research
|
January 1, 1982
Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial
J L Misset, G Mathé, J Gastiaburu, et al.
Bone Marrow Transplantation
|
May 29, 2007
Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies
C Ferry, G Gemayel, V Rocha, et al.
Leukemia
|
September 16, 1998
Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantation
G Socié, J M Cayuela, B Raynal, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1982
[Treatment of leukemias and lymphomas with interferons: I. Trial of myeloma therapy with human beta-interferon]
J L Misset, G Mathé, J Gastiaburu, et al.
Cancer Treatment Reports
|
May 1, 1978
Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine
G Mathé, J L Misset, F De Vassal, et al.
Presse Medicale (Paris, France : 1983)
|
October 16, 1999
[Bone marrow transplantation in the treatment of autoimmune diseases. ISAMAIR Group]
D Farge, M Breban, L Guillevin, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|
November 1, 1977
Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumours
G Mathé, B Serrou, M Hayat, et al.
La Nouvelle Presse Medicale
|
February 18, 1978
[Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)]
G Marthé, J L Misset, F de Vassal, et al.
British Journal of Haematology
|
December 12, 2001
Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients
S Maury, J Y Mary, C Rabian, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1982
[Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route]
J L Misset, G Mathé, J Gastiaburu, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 134) with videos related to
Sort By:
Page
of 14
Anticancer Research
|
January 1, 1982
Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial
J L Misset, G Mathé, J Gastiaburu, et al.
Bone Marrow Transplantation
|
May 29, 2007
Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies
C Ferry, G Gemayel, V Rocha, et al.
Leukemia
|
September 16, 1998
Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantation
G Socié, J M Cayuela, B Raynal, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1982
[Treatment of leukemias and lymphomas with interferons: I. Trial of myeloma therapy with human beta-interferon]
J L Misset, G Mathé, J Gastiaburu, et al.
Cancer Treatment Reports
|
May 1, 1978
Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine
G Mathé, J L Misset, F De Vassal, et al.
Presse Medicale (Paris, France : 1983)
|
October 16, 1999
[Bone marrow transplantation in the treatment of autoimmune diseases. ISAMAIR Group]
D Farge, M Breban, L Guillevin, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|
November 1, 1977
Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumours
G Mathé, B Serrou, M Hayat, et al.
La Nouvelle Presse Medicale
|
February 18, 1978
[Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)]
G Marthé, J L Misset, F de Vassal, et al.
British Journal of Haematology
|
December 12, 2001
Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients
S Maury, J Y Mary, C Rabian, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1982
[Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route]
J L Misset, G Mathé, J Gastiaburu, et al.
Page
of 14